Loading...
Thiazide diuretics are known to increase a patient’s risk of hyponatremia (), but the absolute risk is not well characterized. To address this gap, researchers analyzed a Swedish population database, quantifying hyponatremia risk among 80,000 people starting thiazides and 80,000 matched controls starting calcium-channel blockers (CCBs). Notably, this analysis did not include the thiazide-like diuretic chlorthalidone; it included only hydrochlorothiazide and bendroflumethiazide, a drug not available in the United States.
Overall, the cumulative 2-year incidence of hyponatremia (<130 mEq/l) was higher with thiazides than with CCBs (2.5% vs. 1.8%).
This difference was driven primarily by older age: Only a modest differe…